Lantheus Medical Imaging, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 331 Treble Cove Road, North Billerica, Massachusetts (MA) 01862, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 1216602 · DUNS 176786812
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-09
- NAIBioresearch Monitoring2023-12-21
- NAIDrug Quality Assurance2018-01-19
- NAIBioresearch Monitoring2015-03-05
- VAIDrug Quality Assurance2015-03-05
- VAIDrug Quality Assurance2013-06-20
- VAIDrug Quality Assurance2011-07-18
- VAIDrug Quality Assurance2009-07-09
- NAIBioresearch Monitoring2009-07-01
Drugs this plant is listed as making
5 distinct drugs across 9 products name this site in their FDA label.
- Bicisate dihydrochlorideLantheus Medical Imaging, Inc.
- perflutrenLantheus Medical Imaging, Inc.
- Technetium Tc99m GeneratorLantheus Medical Imaging, Inc.
- Tetrakis(2-Methoxyisobutylisocyanide)copper(I) TetrafluoroborateLantheus Medical Imaging, Inc.
- Xenon XE-133Lantheus Medical Imaging, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.